On March 23, within the framework of interaction between the AEB Healthcare and Pharmaceutical Committee and the Intellectual Property Commitee, an expert discussion of the issues of protecting intellectual property rights in the pharmaceutical industry in Russia and the EAEU took place.

The experts analyzed the current approach of Rospatent and the Eurasian Patent Office to patent protection, discussed the difficulties in enforcement in Russia and the Eurasian Economic Union, noted differences in approaches to assessing patentability of inventions in the field of pharmaceuticals in the Eurasian space, insufficient level of harmonization in assessing the patentability of inventions in this area between Rospatent and the Eurasian Patent Office.